Dermatological lesions among people living with HIV in Turkey

Abstract

This study aimed to document the dermatoses and their relationships with CD4⁺ T lymphocyte counts and clinical stages of disease among people living with HIV followed by our Clinical Department, to investigate the effect of antiretroviral therapy (ART) on findings and to compare with real-world data. Medical records of people living with HIV were analyzed retrospectively in our outpatient clinic from January 2005 to June 2017. A total of 500 patient files were examined. 179 patients with dermatoses were included in the study. Demographic data, clinical and laboratory findings, dermatological findings, type and distribution of lesions, serological and histopathological examinations, diagnosis, treatment, and follow-up of patients were transferred to data forms. 84.4% of the patients were male and the mean age was 38.65 ± 11.6 years. The median CD4⁺ T lymphocyte count was 253/mm3 (range:0–1067). At least one dermatosis was present in 69.3% of the patients. Compared with their median CD4⁺ T lymphocyte counts, the ratio of CD4⁺ T lymphocytes was significantly lower in the group with three or more dermatoses (p = 0.019). Condyloma acuminatum (15.1%), drug eruption (13.4%), seborrheic dermatitis (11.7%), oral candidiasis (11.2%), dermatophytoses (11.2%), syphilis (8.4%), Kaposi’s sarcoma (8.4%), and telogen effluvium (8.4%) were the most common dermatoses. Kaposi sarcoma (KS), oral candidiasis, onychomycosis, and molluscum contagiosum were significantly higher in the CD4⁺ T lymphocyte <200/mm³ group when CD4⁺ T lymphocyte threshold value was determined as 200/mm³. Compared with other TDF/FTC-containing regimens, a significantly higher proportion of alopecia was reported in patients receiving TDF/FTC/EVG/c (p = 0.007). Dermatoses may be a good clinical marker for detecting clinical stage and diagnosing HIV infection; also, there may be a significant increase in the number of dermatoses in advanced stages. Although there are only a few studies in the literature, it should be kept in mind that ART-associated alopecia rates may increase nowadays when ART is targeted at everyone.

Keywords

Dermatoses HIV/AIDS CD4 + T lymphocyte counts

Get full access to this article

View all access options for this article.

References

Centers for Disease Control (CDC) . Kaposi’s sarcoma and pneumocystis pneumonia among homosexual men--New York city and California. MMWR Morb Mortal Wkly Rep 1981; 30: 305–308.

Mignard

Spira

Morlat

, et al. Correlation of skin disorders with CD4 lymphocyte counts in patients with HIV/AIDS. J Am Acad Dermatol 1998; 39: 298–299.

Jensen

Weismann

Sindrup

, et al. Incidence and prognostic significance of skin disease in patients with HIV/AIDS: a 5-year observational study. Acta Derm Venereol 2000; 80: 140–143.

Zancanaro

PCQ

McGirt

Mamelak

, et al. Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. J Am Acad Dermatol 2006; 54: 581–588.

Altuntaş Aydin

Kumbasar Karaosmanoğlu

Korkusuz

, et al. Mucocutaneous manifestations and the relationship to CD4 lymphocyte counts among Turkish HIV/AIDS patients in Istanbul, Turkey. Turk J Med Sci 2015; 45: 89–92.

Schneider

Whitmore

Glynn

, et al. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged. MMWR Recomm Rep 2008; 57(RR-10): 1–12.

Fernandes

Bhat

. Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count. Int J STD AIDS 2015; 26: 414–419.

Fauci

Clifford Lane

. Human immunodeficiency virus disease: AIDS and related disorders. In: Kasper

Fauci

(eds). Harrison’s Infectious Diseases. 2nd ed. New York, USA: McGraw-Hill; 2013, pp. 842–942.

Goh

B-K

Chan

RKW

Sen

, et al. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts. Int J Dermatol 2007; 46: 695–699.

10.

Tzung

T-Y

Yang

C-Y

Chao

S-C

, et al. Cutaneous manifestations of human immunodeficiency virus infection in Taiwan. Kaohsiung J Med Sci 2004; 20: 216–224.

11.

Jing

. A retrospective survey of mucocutaneous manifestations of HIV infection in Malaysia: analysis of 182 cases. The J Dermatol 2000; 27: 225–232.

12.

Palefsky

Holly

Ralston

, et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2001; 183: 383–391.

13.

Shobhana

Guha

Neogi

. Mucocutaneous manifestations of HIV infection. Indian J Dermatol Venereol Leprol 2004; 70: 82–86.

14.

Azfar

Khan

Zia

, et al. Frequency of mucocutaneous manifestations in HIV positive Pakistani patients. J Pak Assoc Dermatol 2011; 21: 149–153.

15.

Mawenzi

Oguttu

Williams

, et al. Epidemiology and clinical spectrum of cutaneous diseases manifesting among newly diagnosed HIV seropositive adults in Nakuru country-Kenya. Cont J Med Res 2013; 7: 1–9.

16.

Kumarasamy

Solomon

Madhivanan

, et al. Dermatologic manifestations among human immunodeficiency virus patients in South India. Int J Dermatol 2000; 39: 192–195.

17.

Schwartz

Myskowski

. Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients. J Am Acad Dermatol 1992; 27: 583–588.

18.

Coopman

Johnson

Platt

, et al. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670–1674.

19.

Jing

Ismail

. Mucocutaneous manifestations of HIV infection: a retrospective analysis of 145 cases in a Chinese population in Malaysia. Int J Dermatol 1999; 38: 457–463.